Fine Organic raises SEZ investment limit to Rs 420 crore

Fine Organic Industries Limited raised the investment limit for its wholly owned SEZ subsidiary by Rs 120 crore to Rs 420 crore on November 2, 2026, to support a specialty-chemicals manufacturing unit. Fine Organic said the cash investment may be made in one or more tranches through equity shares, preference shares, or both.

Why did Fine Organic raise the SEZ subsidiary investment limit?

Fine Organic raised the limit to fund the setting up of a manufacturing unit by Fine Organic Industries (SEZ) Private Limited, its wholly owned subsidiary. The board increased the permitted investment from Rs 300 crore to Rs 420 crore, an additional Rs 120 crore, at its meeting on November 2, 2026.

The funding will be cash consideration and may be deployed in one or more tranches through subscriptions to equity shares, preference shares, or a combination of both. The November 2 disclosure identifies the subsidiary’s industry as specialty chemicals, the same broad activity that Fine Organic reports as its sole primary operating segment under Indian Accounting Standard 108.

Fine Organic did not disclose the unit’s location, proposed products, installed capacity, construction cost, or commercial-production date. Its Annexure B marked the indicative period for completion as not applicable, so the Rs 420 crore approval is an investment ceiling rather than a disclosed timetable for capital deployment.

The approval came with Fine Organic’s unaudited results for the six months ended September 30, 2026, when standalone revenue from operations was Rs 1,361.56 crore. The filing does not link the new investment limit to a particular revenue target, capacity target, or expected turnover from the proposed SEZ manufacturing unit.

What is the operating status of Fine Organic’s SEZ subsidiary?

Fine Organic’s SEZ subsidiary had not commenced operations and had no turnover history as of the November 2, 2026 disclosure. The subsidiary was incorporated in India on October 10, 2023, and reported net worth of Rs 90.29 crore as at March 31, 2026.

Fine Organic stated that its shareholding and control will not change after the subscriptions because the SEZ subsidiary will remain wholly owned. The transaction is a related-party transaction by virtue of that ownership, while the company said the promoter, promoter group and group companies have no interest in it.

The disclosure did not provide a cost of acquisition or a number of shares to be acquired, consistent with an investment limit rather than a completed subscription. It also marked governmental or regulatory approvals as not applicable for the transaction described, although it did not provide project-specific permits or construction milestones.

The revised Rs 420 crore ceiling exceeds the subsidiary’s disclosed Rs 90.29 crore net worth at March 31, 2026. That comparison does not show how much has already been invested or committed, because Fine Organic authorised future tranches and did not disclose the amount, date, or instrument of any subsequent subscription.

What do Fine Organic’s latest standalone results show?

Fine Organic reported standalone revenue from operations of Rs 1,361.56 crore and net profit of Rs 270.64 crore for the six months ended September 30, 2026. In the corresponding six months ended September 30, 2025, revenue was Rs 1,131.07 crore and net profit was Rs 188.19 crore.

For the quarter ended September 30, 2026, standalone revenue was Rs 693.49 crore, compared with Rs 571.92 crore a year earlier and Rs 668.07 crore in the quarter ended June 30, 2026. Net profit was Rs 135.14 crore, up from Rs 95.36 crore a year earlier but marginally below Rs 135.50 crore in the preceding quarter.

The half-year comparison shows revenue increased by Rs 230.49 crore and net profit by Rs 82.45 crore from the prior-year period. Sequentially, September-quarter revenue rose by Rs 25.42 crore from June 2026, while net profit fell by Rs 0.36 crore, based on the standalone statements approved on November 2, 2026.

Fine Organic’s statutory auditor issued an unmodified limited-review conclusion on the standalone results for the quarter and six months ended September 30, 2026. The company changed its presentation to rounding figures to the nearest crore from the current period, and recast the September 2025 comparatives without changing reported financial performance.

How does the approval compare with Fine Organic’s reported funding position?

Fine Organic had standalone investments of Rs 396.96 crore at September 30, 2026, compared with Rs 261.81 crore at March 31, 2026. Since the SEZ limit was approved only on November 2, 2026, the filing does not identify what portion of either investments balance relates to the non-operational SEZ subsidiary.

Standalone cash and cash equivalents were Rs 33.73 crore at September 30, 2026, down from Rs 47.30 crore at March 31, 2026, while other bank balances were Rs 1,258.05 crore versus Rs 1,259.19 crore. Total standalone equity increased to Rs 2,762.24 crore from Rs 2,514.51 crore across the same dates.

For the six months ended September 30, 2026, standalone cash used for investment in joint ventures and subsidiary companies was Rs 135.15 crore, compared with Rs 74.61 crore in the prior-year period. Net cash from operating activities was Rs 77.58 crore, against Rs 82.58 crore a year earlier, while spending on property, plant and equipment, intangible assets, capital work-in-progress and capital advances was Rs 28.24 crore.

At the consolidated level, capital work-in-progress rose to Rs 170.73 crore at September 30, 2026 from Rs 62.50 crore at March 31, 2026. Consolidated borrowings were Rs 154.68 crore at September 30, comprising Rs 149.38 crore of non-current borrowings and Rs 5.30 crore of current borrowings, compared with Rs 44.95 crore in total six months earlier.

Conclusion

Fine Organic has expanded the authorised funding available to its non-operational SEZ subsidiary by Rs 120 crore, taking the limit to Rs 420 crore for a specialty-chemicals manufacturing unit. The approval accompanies higher standalone half-year revenue of Rs 1,361.56 crore and net profit of Rs 270.64 crore, but it does not establish a construction schedule, capacity, product mix, or future turnover for the project.

The next disclosed development to watch is whether Fine Organic uses the approved limit through the stated equity or preference-share tranches. Project details remain unresolved because the November 2, 2026 filing listed no indicative completion period, while the subsidiary had no operating history or turnover as of that disclosure.